Filing Details
- Accession Number:
- 0001209191-14-022560
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-03-21 21:30:42
- Reporting Period:
- 2014-03-19
- Filing Date:
- 2014-03-21
- Accepted Time:
- 2014-03-21 21:30:42
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1114220 | Keryx Biopharmaceuticals Inc | KERX | Pharmaceutical Preparations (2834) | 134087132 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1434718 | Iii F James Oliviero | C/O Keryx Biopharmaceuticals, Inc. 750 Lexington Avenue New York NY 10022 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock (Exercise Of Stock Options) | Acquisiton | 2014-03-19 | 36,667 | $2.53 | 529,528 | No | 4 | M | Direct | |
| Common Stock (Exercise Of Stock Options) | Acquisiton | 2014-03-19 | 18,622 | $2.78 | 548,150 | No | 4 | M | Direct | |
| Common Stock (Exercise Of Stock Options) | Acquisiton | 2014-03-19 | 48,750 | $4.58 | 596,900 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2014-03-19 | 154,039 | $15.23 | 442,861 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2014-03-20 | 125,000 | $15.04 | 317,861 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2014-03-21 | 13,444 | $15.11 | 304,417 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- Shares of restricted common stock.
- Reflects the weighted average sale price. The range of prices for such transaction is $15.14 to $15.42.
- Reflects the weighted average sale price. The range of prices for such transaction is $14.96 to $15.16.
- Reflects the weighted average sale price. The range of prices for such transaction is $15.10 to $15.16.
- Following the transactions reported on this Form 4, Mr. Oliviero holds 304,417 shares of Keryx restricted common stock and 276,639 stock options (of which 168,000 are vested and exercisable).
Billionaire Hedge Funds
